← All trials

NCT06159166

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 10, 2024
Primary completion
Nov 15, 2027
Completion date
Nov 15, 2028
First posted
Dec 6, 2023
Last posted
Dec 6, 2023
Enrollment
24
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.